A retrospective study to evaluate the ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Biomarker; Pharmacodynamics; Pharmacokinetics
- 09 Dec 2015 New trial record